Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis

References

• Schuetz P, Aujesky D, Muller C, et al. Biomarker-guided personalised emergency medicine for all - hope for another hype? Swiss Med Wkly. 2015;145:w14079. Epub 2015/02/20.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections–hope for hype? Swiss Med Wkly. 2009;139(23–24):318–326. Epub 2009/06/17.
   PubMed Web of Science ®Google Scholar
• Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002;323(1–2):17–29.
   PubMed Web of Science ®Google Scholar
• Laukemann S, Kasper N, Kulkarni P, et al. Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study. Medicine. 2015;94(49):e2264. Epub 2015/12/15.
   PubMed Web of Science ®Google Scholar
• Kutz A, Briel M, Christ-Crain M, et al. Prognostic value of procalcitonin in respiratory tract infections across clinical settings. Crit Care. 2015;19(1):74. Epub 2015/04/19.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Hausfater P, Amin D, et al. Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study. Crit Care. 2015;19(1):377. Epub 2015/10/30.
   PubMed Web of Science ®Google Scholar
• Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004;32(8):1715–1721. Epub 2004/08/03.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Muller B. Procalcitonin in bacterial infections–hype, hope, more or less? Swiss Med Wkly. 2005;135(31–32):451–460. Epub 2005/10/07.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J. 2007;30(3):556–573. Epub 2007/09/04.
   PubMed Web of Science ®Google Scholar
• Linscheid P, Seboek D, Zulewski H, et al. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology. 2005;146(6):2699–2708. Epub 2005/03/12.
   PubMed Web of Science ®Google Scholar
• Kutz A, Grolimund E, Christ-Crain M, et al. Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients. BMC Anesthesiol. 2014;14:102. Epub 2014/11/25.
   PubMed Web of Science ®Google Scholar
• Massaro KS, Costa SF, Leone C, et al. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis. 2007;7:137.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther. 2010;8(5):575–587. Epub 2010/05/12.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322–1331. Epub 2011/08/10.
   PubMed Web of Science ®Google Scholar
• Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008;168(18):2000–2007. discussion 7-8. Epub 2008/10/15.
   PubMed Web of Science ®Google Scholar
• Burkhardt O, Ewig S, Haagen U, et al. A simple procalcitonin-guided strategy results in safe reductions of antibiotic use in patients with symptoms of acute respiratory tract infections in primary care. Eur Respir J. 2010;36:601–607.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600–607. Epub 2004/02/28.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174(1):84–93. Epub 2006/04/11.
   PubMed Web of Science ®Google Scholar
• Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9–19. Epub 2007/01/16.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. Jama. 2009;302(10):1059–1066. Epub 2009/09/10.
   PubMed Web of Science ®Google Scholar
• Kristoffersen KB, Sogaard OS, Wejse C, et al. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission–a randomized trial. Clin Microbiol Infect. 2009;15(5):481–487.
   PubMed Web of Science ®Google Scholar
• Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009;394(2):221–226. Epub 2008/11/27.
   PubMed Web of Science ®Google Scholar
• Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463–474. Epub 2010/01/26.
   PubMed Web of Science ®Google Scholar
• Hochreiter M, Köhler T, Schweiger A, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13(3):R83.
   PubMed Web of Science ®Google Scholar
• Svoboda P, Kantorova I, Scheer P, et al. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepato-Gastroenterology. 2007;54(74):359–363. Epub 2007/05/26.
   PubMed Web of Science ®Google Scholar
• Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2007;177(5):498–505.
   PubMed Web of Science ®Google Scholar
• Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009;34(6):1364–1375.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;9(9):CD007498. Epub 2012/09/14.
   Google Scholar
• Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55(5):651–662. Epub 2012/05/11.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA: Journal Am Med Assoc. 2013;309(7):717–718. Epub 2013/02/21.
   PubMed Web of Science ®Google Scholar
• Sager R, Kutz A, Mueller B, et al. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15. Epub 2017/01/25.
   PubMed Web of Science ®Google Scholar
• De Jong E, Van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819–827. Epub 2016/03/08.
   PubMed Web of Science ®Google Scholar
• Stojanovic I, Schneider JE, Wei L, et al. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective. Clin Chem Lab Med. 2017 Mar 1;55(4):561–570.
   Google Scholar
• Heyland DK, Johnson AP, Reynolds SC, et al. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med. 2011;39(7):1792–1799. Epub 2011/03/02.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Balk R, Briel M, et al. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med. 2015;53(4):583–592. Epub 2015/01/13.
   PubMed Web of Science ®Google Scholar
• Balk R, Kadri S, Robinson S, et al. Effect of procalcitonin testing on healthcare utilization and costs in critically Ill patients in the United States. Chest. 2016 Jan;151(1):23–33.
   PubMed Web of Science ®Google Scholar
• Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011;17(Suppl. 6):E1–E59.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017 Mar;43(3):304–377.
   Google Scholar
• Drozdov D, Schwarz S, Kutz A, et al. Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial. BMC Med. 2015;13(1):104. Epub 2015/05/03.
   PubMed Web of Science ®Google Scholar
• Drozdov D, Schwarz S, Kutz A, et al. Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial. BMC Med. 2015;13:104. Epub 2015/05/03.
   PubMed Web of Science ®Google Scholar
• Nylen ES, Muller B, Becker KL, et al. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis. 2003;36:823–824.
   PubMed Web of Science ®Google Scholar
• Steinbach G, Rau B, Debard AL, et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med. 2004;42(4):440–449.
   PubMed Web of Science ®Google Scholar
• De Wolf HK, Gunnewiek JK, Berk Y, et al. Comparison of a new procalcitonin assay from roche with the established method on the brahms kryptor. Clin Chem. 2009;55(5):1043–1044.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Huber AR, et al. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor(R) and VIDAS(R) automated immunoassays. Clin Biochem. 2010 Feb;43(3):341–344.
   Google Scholar
• Hubl W, Krassler J, Zingler C, et al. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay. Clin Lab. 2003;49(7–8):319–327.
   PubMedGoogle Scholar
• Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (MOSES) study. Crit Care Med. 2017;45:781–789. Epub 2017/03/04.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Maurer P, Punjabi V, et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17(3):R115. Epub 2013/06/22.
   PubMed Web of Science ®Google Scholar
• Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter poststudy survey (ProREAL). Arch Intern Med. 2012;172(9):715–722. Epub 2012/07/12.
   PubMed Web of Science ®Google Scholar
• FDA Available at: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm543160.htm 2017.
   Google Scholar
• Dipalo M, Buonocore R, Gnocchi C, et al. Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800. Clin Chem Lab Med. 2015;53(4):593–597. Epub 2014/12/24.
   PubMed Web of Science ®Google Scholar
• Dupuy AM, Chevrier Q, Olejnik Y, et al. Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay. Clin Chem Lab Med. 2016. Epub 2016/12/18.
   Google Scholar
• Dinter C, Lotz J, Eilers B, et al. Validation of a new sensitive point of care device for rapid measurement of procalcitonin. Crit Care. 2016;20(Suppl 2):P010.
   PubMed Web of Science ®Google Scholar
• Van Kogelenberg M, Zakaria R, Reuver M, et al. ProcalcitoninePoint of Care FIA8000; Geschikt voor de kliniek? http://updatebeknl/NVKC2016/viewAbstractphp?id=54. 2016.
   Google Scholar
• Kwon HJ, Lee J, Park HI, et al. Evaluation of a novel point-of-care test kit, ABSOGEN PCT, in semi-quantitative measurement of procalcitonin in whole blood. J Clin Lab Anal. 2016 Dec 13. doi:10.1002/jcla.22111. [Epub ahead of print].
   Google Scholar
• Rascher D, Geerlof A, Kremmer E, et al. Total internal reflection (TIRF)-based quantification of procalcitonin for sepsis diagnosis–a point-of-care testing application. Biosens Bioelectron. 2014;59:251–258. Epub 2014/04/16.
   PubMed Web of Science ®Google Scholar
• Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011;39(9):2048–2058. Epub 2011/05/17.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Mueller B. To escalate or to de-escalte–that is the question. Crit Care Med. 2011;39(11):2590. author reply 1. Epub 2011/10/19.
   PubMed Web of Science ®Google Scholar
• Sakr Y, Sponholz C, Tuche F, et al. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection. 2008;36(5):396–407.
   PubMed Web of Science ®Google Scholar
• Hunziker S, Hugle T, Schuchardt K, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am. 2010 Jan;92(1):138–148.
   Google Scholar
• Hugle T, Schuetz P, Mueller B, et al. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol. 2008;26(3):453–456. Epub 2008/06/27.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection. 2007;35(5):352–355. Epub 2007/09/21.
   PubMed Web of Science ®Google Scholar
• Marc E, Menager C, Moulin F, et al. [Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak]. Arch Pediatr. 2002;9(4):358–364.
   PubMed Web of Science ®Google Scholar
• Mueller C, Christ-Crain M, Muller B. What cardiologists do need to know about procalcitonin. Clin Lab. 2005;51(1–2):1–4. Epub 2005/02/22.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Affolter B, Hunziker S, et al.. Procalcitonin, CRP and white blood cell levels following hypothermia after cardiac arrest. Eur J Clin Invest. Forthcoming 2010;40:376–381.
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant streptococcus pneumoniae in the United States. N Engl J Med. 2000;343(26):1917–1924.
   PubMed Web of Science ®Google Scholar